Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 39

Results For "tablets"

429 News Found

Granules receives ANDA approval for amphetamine mixed salts
Drug Approval | December 30, 2021

Granules receives ANDA approval for amphetamine mixed salts

The current annual U.S. market for amphetamine mixed salts, USP 1.25mg, 1.875mg, 2.5mg, 3.125mg, 3.75mg, 5mg, 7.5mg immediate release tablets strengths is approximately US $ 335 million, according to MAT, Oct 2021 IQVIA/IMS Health


Pfizer’s Covid-19 pill gets U.S. FDA clearance
Drug Approval | December 23, 2021

Pfizer’s Covid-19 pill gets U.S. FDA clearance

Pfizer raises production projections from 80 million to 120 million courses of treatment in 2022, as a result of continued investments to support the manufacturing and distribution of Paxlovid


U.S. FDA approves first and only injectable option for HIV prevention
Drug Approval | December 21, 2021

U.S. FDA approves first and only injectable option for HIV prevention

Given as few as six times per year and demonstrated superior efficacy to a daily oral PrEP option (FTC/TDF tablets) in reducing the risk of HIV acquisition


Shilpa Medicare launch Prucalshil for treatment of constipation
Drug Approval | December 21, 2021

Shilpa Medicare launch Prucalshil for treatment of constipation

Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients


EMA approves Pfizer’s Covid-19 anti-viral candidate
News | December 17, 2021

EMA approves Pfizer’s Covid-19 anti-viral candidate

EMA’s CHMP advice states that Paxlovid can be used for treatment of adults with Covid-19 who do not require supplemental oxygen and who are at increased risk of progressing to severe disease


Unichem Labs gets ANDA approval for schizophrenia medicine
Drug Approval | December 03, 2021

Unichem Labs gets ANDA approval for schizophrenia medicine

The product will be commercialized from Unichem's Ghaziabad plant


NFHS-5 shows momentum towards achieving SDG
News | November 25, 2021

NFHS-5 shows momentum towards achieving SDG

The main objective of successive rounds of the NFHS is to provide reliable and comparable data relating to health and family welfare and other emerging issues


DawaDost rolls out diabetes medicine at Re 1 per day
Startup | November 13, 2021

DawaDost rolls out diabetes medicine at Re 1 per day

The start-up has announced the scheme to mark World Diabetes Day


Meiji Seika Pharma to build new facility in Bangalore to expand CMO business
Biotech | November 08, 2021

Meiji Seika Pharma to build new facility in Bangalore to expand CMO business

The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23


Novartis AG wins case against four domestic pharma firms
News | November 03, 2021

Novartis AG wins case against four domestic pharma firms

The injunction order has been passed against Natco Pharma, Torrent Pharmaceuticals, Eris Lifesciences and Windlas Biotech